Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Fenwick

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failureClaire McKenna, Simon Walker, Paula Lorgelly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task ForceClaire Rothery, Mark Strong, Hendrik Erik Koffijberg, et al.
Annals of Internal Medicine|November 3, 2004
Cost-effectiveness of rhythm versus rate control in atrial fibrillationDeborah A Marshall, Adrian R Levy, Humberto Vidaillet, et al.
BMC Medicine|June 23, 2016
The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysisStewart W Mercer, Bridie Fitzpatrick, Bruce Guthrie, et al.
BMC Public Health|July 29, 2008
The 'Walking for Wellbeing in the West' randomised controlled trial of a pedometer-based walking programme in combination with physical activity consultation with 12 month follow-up: rationale and study designClaire F Fitzsimons, Graham Baker, Annemarie Wright, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer ImmunotherapiesStephen Palmer, Isabelle Borget, Tim Friede, et al.
Journal of Medical Economics|June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosisCelia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
The Lancet. Psychiatry|September 12, 2015
Practice nurse health checks for adults with intellectual disabilities: a cluster-design, randomised controlled trialSally-Ann Cooper, Jill Morrison, Linda M Allan, et al.
Lancet (London, England)|January 25, 2014
A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trialKate Hunt, Sally Wyke, Cindy M Gray, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failureClaire McKenna, Simon Walker, Paula Lorgelly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task ForceClaire Rothery, Mark Strong, Hendrik Erik Koffijberg, et al.
Annals of Internal Medicine|November 3, 2004
Cost-effectiveness of rhythm versus rate control in atrial fibrillationDeborah A Marshall, Adrian R Levy, Humberto Vidaillet, et al.
BMC Medicine|June 23, 2016
The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysisStewart W Mercer, Bridie Fitzpatrick, Bruce Guthrie, et al.
BMC Public Health|July 29, 2008
The 'Walking for Wellbeing in the West' randomised controlled trial of a pedometer-based walking programme in combination with physical activity consultation with 12 month follow-up: rationale and study designClaire F Fitzsimons, Graham Baker, Annemarie Wright, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer ImmunotherapiesStephen Palmer, Isabelle Borget, Tim Friede, et al.
Journal of Medical Economics|June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosisCelia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
The Lancet. Psychiatry|September 12, 2015
Practice nurse health checks for adults with intellectual disabilities: a cluster-design, randomised controlled trialSally-Ann Cooper, Jill Morrison, Linda M Allan, et al.
Lancet (London, England)|January 25, 2014
A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trialKate Hunt, Sally Wyke, Cindy M Gray, et al.
Pageof 5